Page last updated: 2024-08-26

3,4-dihydroxybenzylamine and Coronary Heart Disease

3,4-dihydroxybenzylamine has been researched along with Coronary Heart Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nayler, WG; Sturrock, WJ	1

Other Studies

1 other study(ies) available for 3,4-dihydroxybenzylamine and Coronary Heart Disease

Article	Year
An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts. Journal of molecular and cellular cardiology, 1984, Volume: 16, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Coronary Disease; Diltiazem; Dopamine; Epinephrine; Heart; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains; Species Specificity; Verapamil	1984

Article

Year

An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused hearts.

Journal of molecular and cellular cardiology, 1984, Volume: 16, Issue:4

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Coronary Disease; Diltiazem; Dopamine; Epinephrine; Heart; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains; Species Specificity; Verapamil

1984